Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects. 2015

Paul P Dobesh, and Jamela F Urban, and Scott W Shurmur, and Julie H Oestreich
Department of Pharmacy Practice, University of Nebraska Medical Center College of Pharmacy, Omaha, Nebraska 68198-6045 USA.

BACKGROUND Ideal conditions for platelet reactivity testing are critical for optimal selection of a P2Y12 inhibitor. Data are inconsistent regarding the impact of high-fat meals on test assessment. METHODS Participants included 12 healthy subjects not taking antiplatelet drugs after a 12-hour fast. After baseline assessment, subjects were given a 600 mg dose of clopidogrel. Four hours later, maximum platelet inhibition was tested in the fasting state by light transmission aggregometry (LTA), VerifyNow P2Y12, vasodilator-stimulated phosphoprotein (VASP), and whole blood aggregometry (WBA). Subjects were then provided a high-fat meal, and platelet function was evaluated two hours later. Change in measured platelet aggregation by LTA was the primary endpoint of the study. The Wilcoxon Rank Sum test was used to compare the change in platelet reactivity between fasting and non-fasting conditions. The Spearman rho (ρ) correlation coefficient was used to evaluate the association between fasting platelet reactivity and the change following a high-fat meal. RESULTS No significant change occurred in maximal light transmission, as assessed by LTA with 5 μM ADP (p = 0.15) and with 20 μM ADP (p = 0.07). There was a significant change in the area under the curve with 5 μM ADP (p = 0.03) but not with 20 μM ADP (p = 0.18). Although there was no significant change with the VerifyNow P2Y12 assay (p = 0.16), the change was correlated with the initial fasting value (Spearman's rho p = 0.008). The VASP assay and WBA varied minimally. CONCLUSIONS The high-fat meal did not significantly alter platelet function assessment of commonly used platelet function tests. Greater intra-subject variability existed for the optically-dependent compared with non-optically dependent tests. BACKGROUND NCT01307657.

UI MeSH Term Description Entries

Related Publications

Paul P Dobesh, and Jamela F Urban, and Scott W Shurmur, and Julie H Oestreich
June 2010, European journal of applied physiology,
Paul P Dobesh, and Jamela F Urban, and Scott W Shurmur, and Julie H Oestreich
February 1997, The American journal of cardiology,
Paul P Dobesh, and Jamela F Urban, and Scott W Shurmur, and Julie H Oestreich
January 1979, Thrombosis research,
Paul P Dobesh, and Jamela F Urban, and Scott W Shurmur, and Julie H Oestreich
January 2003, The American journal of clinical nutrition,
Paul P Dobesh, and Jamela F Urban, and Scott W Shurmur, and Julie H Oestreich
October 2010, Journal of clinical pharmacology,
Paul P Dobesh, and Jamela F Urban, and Scott W Shurmur, and Julie H Oestreich
October 2005, Metabolism: clinical and experimental,
Paul P Dobesh, and Jamela F Urban, and Scott W Shurmur, and Julie H Oestreich
March 1993, Clinical science (London, England : 1979),
Paul P Dobesh, and Jamela F Urban, and Scott W Shurmur, and Julie H Oestreich
July 1999, Digestive diseases and sciences,
Paul P Dobesh, and Jamela F Urban, and Scott W Shurmur, and Julie H Oestreich
July 2015, Gut and liver,
Paul P Dobesh, and Jamela F Urban, and Scott W Shurmur, and Julie H Oestreich
October 2007, American heart journal,
Copied contents to your clipboard!